ACHVAchieve Life Sciences, Inc.
What is the market doing?
No clear lean: nothing decisive, though a crowded short (+17% of shares).
Choppy, but holding above its 200-day average. Price is +15% vs its 200-day average.
A crowded short, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ACHV is trading
Achieve Life Sciences, Inc. is +27% over the past year while the S&P 500 is +16%: 11 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +15%
vs 200-day average · a clear uptrend
- RSI (14)
- 36
RSI (14) · neutral
- Below its 52-week high
- 24%
Below its 52-week high
Details›
- Last close2026-10-23
- $6.48
- 1 monthS&P 500 −0.94%
- −17%
- 1 yearS&P 500 +16%
- +27%
- 5 yearsS&P 500 +86%
- −20%
- vs 50-day average$7.55
- −14%
- 52-week high
- $8.54
- 52-week low
- $2.65
- Annualised volatility
- 86%
| Year | Return |
|---|---|
| 2026 (year to date) | +30% |
| 2025 | +41% |
| 2024 | −15% |
| 2023 | +68% |
| 2022 | −69% |
| 2021 | −4.0% |
| 2020 | −24% |
| 2019 | −56% |
| 2018 | −91% |
| 2017 | −76% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +20% |
| Feb | 10 | 3 of 10 | +0.82% |
| Mar | 10 | 5 of 10 | −1.2% |
| Apr | 10 | 5 of 10 | +10% |
| May | 10 | 3 of 10 | −1.5% |
| Jun | 10 | 2 of 10 | −17% |
| Jul | 11 | 6 of 11 | +6.6% |
| Aug | 11 | 4 of 11 | −7.7% |
| Sep | 11 | 6 of 11 | −7.2% |
| Oct | 11 | 1 of 11 | −9.0% |
| Nov | 10 | 4 of 10 | −1.1% |
| Dec | 10 | 4 of 10 | −11% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.